Published in J Reprod Immunol on January 01, 1985
Ectoplasmic specialization: a friend or a foe of spermatogenesis? Bioessays (2007) 1.52
An intracellular trafficking pathway in the seminiferous epithelium regulating spermatogenesis: a biochemical and molecular perspective. Crit Rev Biochem Mol Biol (2009) 1.33
NC1 domain of collagen α3(IV) derived from the basement membrane regulates Sertoli cell blood-testis barrier dynamics. Spermatogenesis (2013) 0.84
Microtubule affinity-regulating kinase 4 (MARK4) is a component of the ectoplasmic specialization in the rat testis. Spermatogenesis (2012) 0.82
Basement Membrane Laminin α2 Regulation of BTB Dynamics via Its Effects on F-Actin and Microtubule Cytoskeletons Is Mediated Through mTORC1 Signaling. Endocrinology (2017) 0.75
Regulation of spermatogenesis by a local functional axis in the testis: role of the basement membrane-derived noncollagenous 1 domain peptide. FASEB J (2017) 0.75
The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen. Cell Immunol (1981) 2.60
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun (1997) 2.44
Vibrio cholerae O1 can assume a chlorine-resistant rugose survival form that is virulent for humans. J Infect Dis (1996) 2.17
Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol (1998) 2.11
Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest (1984) 2.00
Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens (2004) 1.86
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun (1999) 1.66
Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect Immun (2000) 1.63
Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes. Infect Immun (1999) 1.55
Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun (2001) 1.50
Role of EspB in experimental human enteropathogenic Escherichia coli infection. Infect Immun (2000) 1.47
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans. Infect Immun (2000) 1.44
Impact of immunoglobulin isotype and sperm surface location of antisperm antibodies on fertilization in vitro in the human. Fertil Steril (1995) 1.43
Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J Infect Dis (1994) 1.43
Structural components of epithelial and endothelial basement membranes. Biochemistry (1969) 1.36
Differential expression of Vibrio vulnificus capsular polysaccharide. Infect Immun (1999) 1.36
Host-Salmonella interaction: human trials. Microbes Infect (2001) 1.35
The role of interleukin 1 in acute phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis. Ann N Y Acad Sci (1982) 1.33
Structure and expression of two porcine genomic clones encoding class I MHC antigens. J Immunol (1985) 1.32
Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect Immun (1996) 1.32
In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors. Infect Immun (2000) 1.32
Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. J Infect Dis (1993) 1.28
Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression. J Immunol (1988) 1.26
Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge. J Clin Invest (1992) 1.21
Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses. Clin Immunol (1999) 1.20
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine (2011) 1.15
Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin Immunol (2000) 1.14
Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line. J Invest Dermatol (1983) 1.12
Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells. Infect Immun (1999) 1.12
Characterization of a porcine genomic clone encoding a major histocompatibility antigen: expression in mouse L cells. Proc Natl Acad Sci U S A (1982) 1.12
Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans. Mucosal Immunol (2008) 1.10
A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model. Vaccine (2000) 1.06
DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin. Vaccine (2000) 1.05
Trypanosoma cruzi reduces the number of high-affinity IL-2 receptors on activated human lymphocytes by suppressing the expression of the p55 and p70 receptor components. J Immunol (1989) 1.04
Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain. J Immunol (2000) 1.04
Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells. J Immunol (1990) 1.03
Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones. J Immunol (1987) 1.01
Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915. Infect Immun (2001) 1.01
Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes. Infect Immun (1989) 1.01
The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1. J Immunol (1987) 0.98
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. Vaccine (2009) 0.97
Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates. Clin Immunol (2011) 0.97
Thymic hormones--a clinical update. Springer Semin Immunopathol (1986) 0.95
Endometrial dating and determination of the window of implantation in healthy fertile women. Fertil Steril (2000) 0.95
Tumour necrosis factor-alpha released by testicular macrophages induces apoptosis of germ cells in autoimmune orchitis. Hum Reprod (2008) 0.93
Immunochemistry of sheep anterior lens capsule. Biochim Biophys Acta (1970) 0.93
Decreased human IL-2 receptor expression due to a protozoan pathogen. Immunol Today (1989) 0.92
Diminished peripheral blood monocyte DR antigen expression in systemic lupus erythematosus. Clin Exp Rheumatol (1985) 0.91
Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes. Int J Immunopharmacol (1990) 0.91
An epidermal cell-derived cytokine triggers the in vivo synthesis of serum amyloid A by hepatocytes. J Immunol (1982) 0.91
Effect of mouse interferon on the expression of a porcine major histocompatibility gene introduced into mouse L cells. J Immunol (1984) 0.90
Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes. Eur J Immunol (1999) 0.90
Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones. Proc Natl Acad Sci U S A (1986) 0.89
Generation of primary murine CTL specific for allogeneic and xenogeneic MHC determinants upon stimulation with murine L cells transfected with class I genes. J Immunol (1985) 0.89
Thymosin in the early diagnosis and treatment of high risk homosexuals and hemophiliacs with AIDS-like immune dysfunction. Ann N Y Acad Sci (1984) 0.88
Sequential study of the histopathology and cellular and humoral immune response during the development of an autoimmune orchitis in Wistar rats. Am J Reprod Immunol (1989) 0.88
Antibodies to laminin and immunohistochemical localization of laminin in chronic chagasic cardiomyopathy: a review. Mol Cell Biochem (1993) 0.88
Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson's disease. Nitric Oxide (2000) 0.87
Trypanosoma cruzi-induced decrease in the level of interferon-gamma receptor expression by resting and activated human blood lymphocytes. Parasite Immunol (1995) 0.87
Deficient DR antigen expression on human cord blood monocytes: reversal with lymphokines. Clin Immunol Immunopathol (1984) 0.86
Trypanosoma cruzi-induced suppression of human peripheral blood lymphocytes activated via the alternative (CD2) pathway. Infect Immun (1990) 0.85
Cytotoxic action of an antiserum to soluble collagen on tissue culture of fibroblasts. Proc Soc Exp Biol Med (1970) 0.85
Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1984) 0.84
Properties of murine and human epidermal cell-derived thymocyte-activating factor. Fed Proc (1983) 0.84
The Trypanosoma cruzi immunosuppressive factor (TIF) targets a lymphocyte activation event subsequent to increased intracellular calcium ion concentration and translocation of protein kinase C but previous to cyclin D2 and cdk4 mRNA accumulation. Mol Biochem Parasitol (1998) 0.84
Mechanisms underlying immunosuppression induced by Trypanosoma cruzi. Parasitol Today (1990) 0.84
Association of HLA alleles with Plasmodium falciparum severity in Malian children. Tissue Antigens (2011) 0.84
Feline parvovirus propagates in cat bone marrow cultures and inhibits hematopoietic colony formation in vitro. Blood (1989) 0.84
The chemistry of sheep anterior lens capsule. Arch Biochem Biophys (1970) 0.83
[T lymphoma of immature phenotype associated with polycythemia vera]. Medicina (B Aires) (1991) 0.83
Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes. Immunology (1991) 0.83
Urinary neopterin in volunteers experimentally infected with Plasmodium falciparum. Trans R Soc Trop Med Hyg (1992) 0.83
Treatment of HTLV-III/LAV-infected patients with D-penicillamine. Arzneimittelforschung (1986) 0.82
Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine--HGP-30-KLH. Int J Immunopharmacol (1991) 0.82
Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C. J Biotechnol (2000) 0.82
[Experimental autoimmune orchitis]. Medicina (B Aires) (1989) 0.82
Gelcap-assisted fiberoptic nasogastric feeding tube placement. Ear Nose Throat J (1996) 0.82
Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells. Arthritis Rheum (1999) 0.81
Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation. Infect Immun (1991) 0.81
Biosynthesis of basement membrane by parietal yolk sac cells. Differentiation (1982) 0.81
Thymic physiology and biochemistry. Adv Clin Chem (1987) 0.81
Restriction fragment length polymorphism in HLA class II genes of Latin-American Caucasian celiac disease patients. Hum Immunol (1989) 0.81
Antilaminin IgG binds and interacts with cardiac cholinergic receptors. Can J Physiol Pharmacol (1990) 0.81
Synergistic spermicidal activity of neem seed extract, reetha saponins and quinine hydrochloride. Contraception (1994) 0.81
Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis. J Reprod Immunol (2009) 0.81
Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi? Immunology (1993) 0.80
Thymosin in the staging and treatment of HTLV-III positive homosexuals and hemophiliacs with AIDS-related immune dysfunction. Adv Exp Med Biol (1985) 0.80
Transfer of experimental allergic orchitis with immune RNA studies in vivo. Clin Exp Immunol (1978) 0.80
Interferon regulation of DR antigen expression and alloantigen-presenting capabilities of the promyelocytic cell line HL60. Scand J Immunol (1985) 0.80
Functional and phenotypic characteristics of testicular macrophages in experimental autoimmune orchitis. J Pathol (2008) 0.80
Alterations induced by Trypanosoma cruzi in activated mouse lymphocytes. Parasite Immunol (1993) 0.80
Antigens of the basement membranes of the seminiferous tubules induce autoimmunity in Wistar rats. J Reprod Immunol (1982) 0.79
Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies. Clin Auton Res (1994) 0.79